Cardinal health reaffirms fiscal 2024 non-gaap eps guidance and long-term targets amidst nonrenewal of optumrx customer contracts

Dublin, ohio , april 22, 2024 /prnewswire/ -- cardinal health (nyse: cah) announced today that its pharmaceutical distribution contracts with optumrx, which expire at the end of june 2024, will not be renewed. the company reaffirmed its fiscal 2024 non-gaap diluted eps guidance of $7.20 to $7.35.
CAH Ratings Summary
CAH Quant Ranking